Schneider BP, Jiang G, Ballinger TJ, Shen F, et al. BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer. J Clin Oncol 2021 Dec 15:JCO2101657. doi: 10.1200/JCO.21.01657.
PMID: 34910554